Gas Versus Air Tamponade in Surgery for Full-Thickness Macular Hole: A Systematic Review and Meta-analysis.
Al-Burak, Butt … Serhan
Ophthalmol Retina·Sep 18, 2026
This systematic review and meta-analysis of 14 studies (1,585 eyes) found no statistically significant difference in anatomical closure or visual acuity between fluorinated gas and room air tamponade after macular hole surgery, though evidence certainty was very low throughout.
Scleral Buckling in Primary Vitrectomy for Giant Retinal Tears: A Systematic Review and Meta-Analysis of Anatomical and Functional Outcomes.
Zhang, Lai … Williams
Ophthalmol Retina·Sep 17, 2026
This meta-analysis of 11 studies found that adjunctive scleral buckling (SB) with PPV for giant retinal tear-associated retinal detachments did not improve overall single-surgery anatomic success, final anatomic success, or final visual acuity compared to PPV alone, though a subgroup analysis suggested a potential benefit of PPV+SB in younger patients (mean age <40 years).
Global burden of age-related macular degeneration, with forecast up to 2050: a modelling study.
Jeong, Jeon … Yon
Ophthalmol Retina·Sep 18, 2026
A global modelling study estimated AMD prevalence at 10.03% in 2021 using the standardized Beckman classification across 204 countries, projecting continued increases through 2050 while identifying tobacco reduction and increased physical activity as modifiable risk factors that could meaningfully reduce disease burden.
Neovascular and Non-Neovascular Subretinal Fluid Associated with Angioid Streaks: Comparative Imaging Analysis with Long-Term Follow-up.
Feo, Bousquet … Sarraf
Ophthalmol Retina·Sep 18, 2026
In this multicenter retrospective study of 53 eyes with angioid streak-associated subretinal fluid, long-term visual and structural outcomes were comparable between neovascular (70%) and non-neovascular (30%) phenotypes, underscoring that SRF alone should not be interpreted as evidence of CNV activity.
Association of reticular pseudodrusen burden and dark adaptation in non-advanced age-related macular degeneration: a cross-sectional and longitudinal study.
Ong, Struvyen … Lains
Ophthalmol Retina·Sep 17, 2026
Greater quantitative reticular pseudodrusen (RPD) burden—measured by automated deep learning assessment of en face area and volume—is independently associated with impaired rod-mediated dark adaptation and predicts faster functional decline over time in non-advanced AMD, supporting its role as a prognostic structural biomarker.
Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy.
Chaikitmongkol, Boonyot … Bressler
JAMA Ophthalmol·Sep 17, 2026
In this prospective cohort study of PCV eyes achieving complete polypoidal regression after aflibercept, approximately half remained quiescent on PRN management over 2 years, while the other half recurred—with 21% losing 10 or more letters and 36% developing new hemorrhage at recurrence.
The first-in-human autologous iPSC-derived RPE sheet transplantation demonstrated sustained graft survival and structural stability at 10-year follow-up in a single patient with neovascular AMD, providing long-term safety evidence for iPSC-based retinal cell therapy.
CRVO, BRVO, retinal ischemia, macular edema from RVO
Re: Bellanda et al: Screening for retinal ischemic perivascular lesions in patients undergoing cardiovascular assessment: a cross-sectional study (Ophthalmol Retina. 2026;10:34-352).
Rossi, Gallo … Paques
Ophthalmol Retina·Sep 18, 2026
Abstract not available — see full article for details.
Bilateral Vaso-Occlusive Retinopathy Unmasking Primary Antiphospholipid Syndrome in a Child.
Mbarek, Blel … Messaoud
Ocul Immunol Inflamm·Sep 19, 2026
A 12-year-old girl presented with bilateral vaso-occlusive retinopathy as the initial manifestation of primary antiphospholipid syndrome (APS), highlighting the importance of antiphospholipid antibody testing in pediatric patients with unexplained retinal vascular occlusive disease.
Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study.
Nijim, Pham … Arepalli
Am J Ophthalmol·Sep 19, 2026
A TriNetX database study of over 30 million U.S. children found that non-infectious pediatric uveitis incidence and prevalence rose significantly from 2016 to 2025, with anterior uveitis predominating but intermediate and posterior subtypes carrying the greatest ocular morbidity and vision loss.
Bilateral Maculopathy in an Infant Following Measles, Mumps, Rubella, and Varicella-Zoster (MMRV) Vaccination.
Ben-Avi & Amer
Ocul Immunol Inflamm·Sep 19, 2026
A 13-month-old infant developed bilateral retinitis, retinal vasculitis, and exudative retinal detachment two weeks after MMRV vaccination, with positive measles serology but negative PCR, ultimately resulting in stable bilateral macular scars and final visual acuity of 6/9 OU over a six-year follow-up.
When OCT Speaks Before the Fundus Does: Early ASHH Sign Revealing Acute Outer Retinopathy.
Corcuera Munguía, Gallego Pinazo … Armadá Maresca
Ocul Immunol Inflamm·Sep 18, 2026
This case report describes a 19-year-old female with acute outer retinopathy (AOR) whose OCT demonstrated the ASHH sign—indicating complete photoreceptor disruption—before significant fundus changes were visible, underscoring OCT's critical role in early diagnosis of this aggressive AZOOR-spectrum entity.
JAK Inhibitors for Refractory Non-Infectious Ocular Inflammation: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Optimal Positioning.
Uçar Baytaroğlu, Baytaroğlu … Alp
Ocul Immunol Inflamm·Sep 18, 2026
This systematic review and meta-analysis of seven studies found that systemic JAK inhibitors demonstrate a consistent favorable direction in refractory non-infectious intraocular inflammation, with filgotinib showing the strongest placebo-controlled evidence, though extreme heterogeneity and very low certainty evidence limit definitive conclusions.
Biologic Therapy in Refractory Non-Infectious Uveitis: An Analysis of 60 Cases at a Tertiary Eye Care Centre from South India.
Agrawal, Raghu … Biswas
Ocul Immunol Inflamm·Sep 18, 2026
In a retrospective series of 60 patients with refractory non-infectious uveitis (NIU) at a South Indian tertiary centre, biologic therapy—predominantly adalimumab—achieved significant intraocular inflammation control with stable visual acuity and a favorable safety profile across pediatric and adult populations.
Real-World Safety and Effectiveness of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis: A Post-Marketing Surveillance Study in Korea.
Choi, Ryu & Woo
Ocul Immunol Inflamm·Sep 17, 2026
This Korean post-marketing surveillance study demonstrated that adalimumab (Humira) is safe and potentially effective in real-world patients with non-infectious intermediate, posterior, or panuveitis, with significant improvements in anterior chamber inflammation and vitreous haze at 22 weeks and no serious drug-related adverse events.
Ocular Toxoplasmosis Masquerading as Acute Retinal Necrosis and Cytomegalovirus Retinitis: A Systematic Review.
Mikhail, Macaron … Burnier
Ophthalmol Retina·Sep 16, 2026
Atypical ocular toxoplasmosis frequently masquerades as ARN or CMV retinitis, causing a mean diagnostic delay of 26.4 days during which ineffective empiric antivirals are administered, resulting in poor visual outcomes with over half of affected eyes retaining final visual acuity worse than 20/200.
Putative mechanisms of ocular inflammation in syphilis.
Ashander, Furtado … Smith
J Ophthalmic Inflamm Infect·Sep 15, 2026
This review synthesizes multimodal imaging, molecular profiling, and in vitro data to elucidate the pathogenic mechanisms driving retinal inflammation in ocular syphilis, highlighting the central roles of monocytes/macrophages, pro-inflammatory cytokines, and Treponema pallidum-mediated disruption of blood-retinal barriers.
Mortality and Cancer Response in Patients with Immune Check Point Inhibitor Associated Uveitis.
Duong, Oley … Venkat
Ocul Immunol Inflamm·Sep 15, 2026
In a single-center retrospective study, metastatic cancer patients who developed ICI-associated uveitis demonstrated significantly better cancer response rates (75% vs 50%, p=0.03) and a trend toward lower mortality (29% vs 46%) compared to age- and cancer-matched controls, suggesting uveitis may serve as a favorable prognostic biomarker for ICI therapy.
Biologic Switching Strategies for Anti-Tumor Necrosis Factor Alpha Refractory Noninfectious Uveitis:: Systematic Review and Meta-Analysis of Clinical Approach.
Chung, Rodríguez-Fernández … Bodaghi
Ophthalmology·Sep 15, 2026
In this systematic review and meta-analysis of anti-TNFα-refractory noninfectious uveitis, both intraclass and interclass biologic switching demonstrated meaningful response rates (77% vs. 89%, respectively), with interclass switching showing statistically superior outcomes in sensitivity analyses.
Centralized Multidisciplinary Retinoblastoma Care Closes the Outcome Gap: Survival and Globe Salvage for 1000 Eyes from 601 Patients.
Yousef, Halalsheh … Al-Nawaiseh
Ophthalmology·Sep 18, 2026
A centralized multidisciplinary retinoblastoma program at King Hussein Cancer Center achieved a 96% 5-year overall survival and 61% overall eye salvage rate across 1000 eyes from 601 patients over two decades, demonstrating that high-income country outcomes are attainable in resource-limited settings through structured care, capacity building, and telemedicine-supported international collaboration.
Metagenomic Deep Sequencing Identifies Gene Mutations Associated with Chemotherapeutic Resistance in Vitreoretinal Lymphoma.
Pothikamjorn, Doan … Gonzales
Ocul Immunol Inflamm·Sep 17, 2026
Metagenomic deep sequencing (MDS) of intraocular specimens from VRL patients identified gene mutations associated with chemotherapeutic resistance, including methotrexate resistance, with serial sampling in one patient revealing evolving resistance mutations likely reflecting clonal selection under treatment pressure.